Enabling precision medicine with biomarkers of response to treatment in atopic dermatitis: where are we now? A narrative review
Atopic dermatitis (AD) is a complex systemic disease characterized by high heterogeneity both at clinical and pathophysiology levels. While advances in drug development toward a more targeted approach are made, treatment and management of AD patients are still happening according to the one-size-fit...
Saved in:
| Main Authors: | Andrea Chiricozzi, Anna Levi, Chiara Palladino, Giampiero Girolomoni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1574697/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unmet needs in atopic dermatitis management: an expert consensus
by: Annalisa Patrizi, et al.
Published: (2022-07-01) -
The diagnosis and management of atopic dermatitis
by: H.F. Jordaan, et al.
Published: (2009-10-01) -
Profile of Transepidermal Water Loss in Non-Atopic Dermatitis and Atopic Dermatitis in Indonesian Adults
by: Damayanti, et al.
Published: (2025-03-01) -
Contemporary therapeutic approaches to atopic dermatitis: role of phototherapy and searching for new possibilities
by: I. V. Kosheleva, et al.
Published: (2021-06-01) -
Budget Impact Analysis of Lebrikizumab for Treating Severe Atopic Dermatitis
by: Ippazio Cosimo Antonazzo, et al.
Published: (2025-07-01)